Eli Lilly & Company - Company Information
Eli Lilly & Company is a global pharmaceutical company that focuses on developing and manufacturing innovative medicines and animal health products. T...Read more
Headquarters
Contact
Linkedin
Company Size10,000+
Stock SymbolLLY
Websitelilly.com
TypePublic
Eli Lilly & Company Technology Stack
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by Eli Lilly & Company
Eli Lilly & Company Employee Profiles
Are you looking for the decision-makers at Eli Lilly & Company? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover Eli Lilly & Company’s employee details in less than 30 secs.
Sign-up for 6sense Revenue AI™ for Sales
To find emails, direct dials, and more for prospects across the web.
Sign Up TodayDownload the 6sense Chrome Extension to get verified contact data of Eli Lilly & Company employees
Install Now
Eli Lilly & Company News & Press Releases
Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are Eli Lilly & Company latest news, alerts and updates.
Eli Lilly launches website to help patients get weight loss drugs
The move will likely improve access to the mega-popular drugs, including Eli Lilly's recently approved drug Zepbound.
4 Jan 2024
Lilly Announces Acquisition of Point Biopharma For $1.4B
Eli Lilly and Company announced on Wednesday, Dec. 27, that it has successfully completed its buyout of the radiopharmaceutical firm that develops cancer treatment, POINT Biopharma Global Inc. The deal is worth about $1.
28 Dec 2023
Lilly Completes Acquisition of POINT Biopharma
Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of POINT Biopharma Global Inc. (NASDAQ: PNT), a radiopharmaceutical company with a pipeline of clinical and preclinical-stage radioligand therapies in development for the treatment of cancer.
27 Dec 2023
Eli Lilly surprised as POINT Biopharma acquisition remains incomplete
Eli Lilly's (LLY) acquisition of radiopharmaceutical company POINT Biopharma (PNT) is facing challenges as investors show lack of interest. Read more here.
5 Dec 2023
Eli Lilly to acquire Mablink Bioscience
PSARlink, an innovative hydrophilic linker using a polysarcosine arm, holds potential for broadening the therapeutic index of ADCs to unleash their full therapeutic impact. Jean-Guillaume Lafay, Mablink™s Chief Executive Officer, stated, œMablink™s ...
22 Oct 2023
Mablink Bioscience Enters an Agreement to be Acquired by Lilly
Lyon, France “ October 18, 2023 - Mablink Bioscience (œMablink), a pre-clinical biotechnology company pioneering the development of next-generation antibody-drug conjugates (ADCs) via its PSARLink proprietary platform, today announced an agreement to be acquired by Eli Lilly and Company (œLilly).
18 Oct 2023
FAQs for Eli Lilly & Company
Explore frequently asked questions about Eli Lilly & Company’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.
How many employees are working at Eli Lilly & Company?
What industry is Eli Lilly & Company in?
What is Eli Lilly & Company's tech stack?
Where are Eli Lilly & Company's headquarters?
Get instant access to B2B contact data across the web
Sign Up Today
